Dr. Benjamin Wahl

Dr. Benjamin Wahl

Drug Discovery Science

PhD in infection biology, Hannover Medical School (Germany)


Identification of phagocytosis regulators using genome-wide CRISPR screens and single cell RNA sequencing


Dr. Michael Schuler

Dr. Michael Schuler

Principal Scientist, Drug Discovery Science

PhD, University of Constance (Germany)

Research interests:

  • RNAi- and Crispr-Cas9-based, genetic screening technologies for target identification/validation and pathway analysis.
  • Phenotypic screening technologies combined with high content image and FACS analysis for target identification/validation and compound characterization.